HomeTLSI • NASDAQ
add
TriSalus Life Sciences Inc
Previous close
$5.11
Day range
$5.14 - $5.51
Year range
$3.50 - $10.17
Market cap
166.20M USD
Avg Volume
38.38K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 9.17M | 41.97% |
Operating expense | 15.00M | -12.64% |
Net income | -10.38M | 21.51% |
Net profit margin | -113.18 | 44.71% |
Earnings per share | -0.26 | 55.83% |
EBITDA | -7.14M | 37.87% |
Effective tax rate | -0.05% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 13.00M | 227.46% |
Total assets | 28.62M | 60.01% |
Total liabilities | 63.00M | 19.28% |
Total equity | -34.37M | — |
Shares outstanding | 32.27M | — |
Price to book | -4.82 | — |
Return on assets | -69.67% | — |
Return on capital | 1,041.35% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -10.38M | 21.51% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2009
Headquarters
Website
Employees
110
